Nov 30 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :
* NUVO PHARMACEUTICALS ANNOUNCES NORMAL COURSE ISSUER BID
* NUVO PHARMACEUTICALS - AUTHORIZED TO ACQUIRE UP TO MAXIMUM OF 919,819 OF ITS COMMON SHARES FOR CANCELLATION OVER NEXT 12 MONTHS
* NUVO PHARMACEUTICALS INC - PURCHASES UNDER NORMAL COURSE ISSUER BID WILL BE FUNDED THROUGH AVAILABLE CASH
* NUVO PHARMACEUTICALS INC - NUVO MAY BEGIN TO PURCHASE COMMON SHARES ON OR ABOUT DECEMBER 4, 2017 AND BID WILL TERMINATE ON DECEMBER 3, 2018